AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Prospects for a Randomized Clinical Trial in Asymptomatic Patients
There's not a good randomized trial currently in asymptomatic patients. We're working with Dr. Agistin to come up with the Agistin 2.0 score, which will be a score that incorporates the non calcified and low density plaque and high risk plaques. So if we're reporting 100 cubic millimeters of calcified plaque on our study, that would equate to a Agistin score of about three to 400. There's some variability because this score is based not just upon the volume of calcium, but the density of the calcium. And so that's why there's some variability. But three to four is about the rule of thumb when you want to get